Juan Luiz Coelho-Silva

9PUBLICATIONS
29CO-AUTHORS
Molecular targetsHaematological tumoursMechanobiologyHaematologyPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|May 25, 2026
Targeting "undruggable" cancer proteins: pharmacological challenges and emerging strategies.

|Nov 08, 2022
The PIP4K2 inhibitor THZ-P1-2 exhibits antileukemia activity by disruption of mitochondrial homeostasis and autophagy.

Keli Lima, Diego Antonio Pereira-Martins, Lívia Bassani Lins de Miranda

|Apr 07, 2021
MLL5 improves ATRA driven differentiation and promotes xenotransplant engraftment in acute promyelocytic leukemia model.

Diego A Pereira-Martins, Isabel Weinhäuser, Juan Luiz Coelho-Silva

|Sep 30, 2020
A multicenter comparative acute myeloid leukemia study: can we explain the differences in the outcomes in resource-constrained settings?

Douglas R A Silveira, Juan L Coelho-Silva, Wellington F Silva

|Jul 12, 2019
Combining gene mutation with gene expression analysis improves outcome prediction in acute promyelocytic leukemia.

Antonio R Lucena-Araujo, Juan L Coelho-Silva, Diego A Pereira-Martins

Pageof 2

Frequent Collaborators

7 joint publications

Diego Antonio Pereira-Martins

4 joint publications

Antonio R Lucena-Araujo

4 joint publications

João Agostinho Machado-Neto

3 joint publications

Israel Bendit